BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4275982)

  • 1. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
    Vassella F; Colombo JP; Gloor RD; Rossi E
    Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tryptophan-nicotinic acid metabolism in psychiatric diseases].
    Chiancone FM
    Acta Vitaminol Enzymol; 1968; 22(3):111-33. PubMed ID: 4239848
    [No Abstract]   [Full Text] [Related]  

  • 5. The binding of tryptophan to plasma proteins and the rate of the inactivation of 5HT released from platelets in Down's syndrome.
    Airaksinen EM; Airaksinen MM
    Ann Clin Res; 1972 Dec; 4(6):361-5. PubMed ID: 4267141
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y; Kaneko M; Yashima Y; Kumashiro H
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

  • 8. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P; Lafourcade G; Jerome H
    Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective binding of 5-HT by blood platelets from children with the trisomy 21 form of Down's syndrome.
    Boullin DJ; Coleman M; O'Brien RA
    J Physiol; 1969 Oct; 204(2):128P+. PubMed ID: 4241928
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of 5-hydroxytryptophan and tryptophan into erythrocytes in vitro.
    Chareziński M; Berbeć H
    Folia Biol (Krakow); 1972; 20(4):355-61. PubMed ID: 4541101
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.
    Boullin DJ; O'Brien RA
    Biochem Pharmacol; 1973 Jul; 22(13):1647-51. PubMed ID: 4269711
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyrin metabolism in Down's syndrome.
    Abdel Kader MM; Abdel Salam E; Emara SH
    Gaz Egypt Paediatr Assoc; 1973 Oct; 21(4):57-61. PubMed ID: 4281401
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of bio-clinical parameters and intelligence in subjects with Down's syndrome and other retardates.
    Klebba JT; Gershbein LL; Marks R
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):159-80. PubMed ID: 4277109
    [No Abstract]   [Full Text] [Related]  

  • 14. Down's syndrome: transport, storage, and metabolism of serotonin in blood platelets.
    Lott IT; Chase TN; Murphy DL
    Pediatr Res; 1972 Sep; 6(9):730-5. PubMed ID: 4264688
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical factors in mental retardation.
    Hsia DY
    Proc Annu Meet Am Psychopathol Assoc; 1967; 56():28-44. PubMed ID: 4966303
    [No Abstract]   [Full Text] [Related]  

  • 16. Circadian rhythm of tryptophan in normal volunteers.
    Steardo L; Bonuso S; Pisanti N; Marano E
    Acta Neurol (Napoli); 1980 Apr; 2(2):86-93. PubMed ID: 6967250
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose tolerance in Down's syndrome.
    Sutnick AI; London WT; Gerstley BJ; Coyne VE; Blumberg BS; Lustbader ED
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):471-80. PubMed ID: 4277496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Distribution and metabolism of 14C-dl-5-hydroxytryptophan in 2 carcinoid patients].
    Waser PG; Wicker-Lüthi U; Wenzl H
    Schweiz Med Wochenschr; 1970 May; 100(19):823-7. PubMed ID: 5312869
    [No Abstract]   [Full Text] [Related]  

  • 19. The synthesis and metabolism of 2,3-dihydro-L-tryptophan and 2,3-dihydro-5-hydroxy-DL-tryptophan.
    Daly JW; Mauger AB; Yonemitsu O; Antonov VK; Takase K; Witkop B
    Biochemistry; 1967 Mar; 6(3):648-54. PubMed ID: 5297946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with 5-hydroxytryptophan of Down's disease].
    Simonsson H
    Nord Med; 1969 Jul; 81(31):952-4. PubMed ID: 4241288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.